In contrast, the CLL cybrids showed a significant increase in TGFβ in response to melatonin (1.2-fold change, p < 0.0001) and resveratrol (1.1-fold change, p < 0.0001) (Figure 5). The gene discussed is TGFB1; the disease is B-cell chronic lymphocytic leukemia.